Play all audios:
Researchers at Eli Lilly want to find out whether migraine sufferers carry a signpost for a molecule implicated in their painful headaches. They think the ingredient that gives hot peppers
their kick will point the way. If they do confirm that people who are sensitive to the fiery capsaicin also have high levels of the migraine-associated molecule, the scientists might have
solved a problem widespread in drug development: How do you know who will benefit from your compound? Migraines afflict about 35 million Americans. There are few effective treatments, and no
new drugs have made it to market in more than 20 years. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS
IN-DEPTH ANALYSIS, NEWSLETTERS, PREMIUM EVENTS, AND NEWS ALERTS. Already have an account? Log in Individual plans Group plans View All Plans To read the rest of this story subscribe to
STAT+. Subscribe